| Date | Form | Description | Docs | XBRL | Pages |
| 09/01/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
20 |
| 07/28/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/27/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/27/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/20/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/19/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/16/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/16/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/15/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/16/21 | 8-K | Current report filing |
|
2 |
Latest News & Events
Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Read More...Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting
Read More...Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy
Read More...